Hormones & Neurodivergence: When Your Brain Isn’t the Only Thing Changing

One of the most common experiences I hear from autistic and ADHD individuals is some version of this:

“Nothing in my life has really changed… so why does everything suddenly feel harder?”

Sometimes the answer isn’t a new stressor.

Sometimes, your biology has changed.

Hormones influence far more than reproduction. They interact with brain function, sleep, emotional regulation, energy, sensory processing, and executive functioning throughout the lifespan. For many neurodivergent individuals, hormonal transitions may coincide with noticeable changes in cognitive capacity and day-to-day functioning—even when routines, relationships, and environmental demands remain relatively stable.

That doesn’t necessarily mean autism or ADHD has become “worse.”

It may mean the brain is working with fewer available resources.

Hormonal changes can be easy to overlook because they often occur gradually. Yet they can alter how efficiently the brain functions from one week, one month, or one life stage to the next. For some people, the changes are subtle. For others, they are significant enough to affect work, relationships, parenting, education, and overall quality of life.

Understanding these changes doesn’t mean attributing every difficulty to hormones. Rather, it means recognizing that biology is one of many factors influencing cognitive and emotional functioning at any given time.

Hormones and the Neurodivergent Brain

Hormonal transitions are associated with changes in cognition, mood, sleep, and executive functioning in many individuals, although the magnitude and clinical significance of these changes vary considerably between people (Eng et al., 2024; Camara et al., 2022; Zhu et al., 2022).

These changes are thought to be influenced, in part, by fluctuations in estrogen, progesterone, and other endocrine systems that interact with multiple neurotransmitter systems and brain networks involved in attention, memory, executive functioning, learning, mood, and emotional regulation (Shansky & Woolley, 2016; Camara et al., 2022).

Hormones do not work in isolation. They interact continuously with sleep, stress, immune function, metabolism, medications, environmental demands, and nervous system regulation. For this reason, two people experiencing the same hormonal transition may have very different cognitive or emotional experiences.

Major hormonal transitions include:

• Puberty

• Menstrual cycle fluctuations

• Premenstrual phase

• Pregnancy

• Postpartum recovery

• Breastfeeding

• Perimenopause

• Menopause

• Hormonal medical conditions

• Hormone replacement therapy (HRT)

• Hormonal contraception

• Gender-affirming hormone therapy

Not everyone experiences these transitions in the same way.

Some notice very little change.

Others describe substantial differences in attention, memory, emotional regulation, sensory processing, or fatigue.

Current research suggests considerable individual variability, influenced by genetics, sleep, stress, medications, overall health, and co-occurring medical conditions (Camara et al., 2022).

What Changes Might Someone Notice?

People commonly describe temporary changes such as:

• Difficulty initiating tasks

• Reduced working memory

• Increased forgetfulness

• Greater cognitive fatigue

• Increased sensory sensitivity

• Greater emotional reactivity

• Reduced tolerance for noise, heat, or multitasking

• Previously compensated autistic characteristics becoming more noticeable

• Executive functioning difficulties and ADHD-related symptoms becoming more difficult to compensate for

Research suggests these experiences may be especially noticeable during the late luteal phase of the menstrual cycle, postpartum, and the menopausal transition, although experiences vary widely between individuals (Eng et al., 2024; Zhu et al., 2022).

Importantly, these changes do not necessarily indicate that someone’s underlying neurodevelopmental condition has progressed.

Instead, they may reflect changes in the efficiency with which existing cognitive systems are functioning.

For many people, these shifts are temporary. Others may notice cyclical patterns that repeat month after month or emerge during specific reproductive life stages. Recognizing these patterns can help guide conversations with healthcare providers and may reduce unnecessary self-blame.

Premenstrual Dysphoric Disorder (PMDD) and Neurodivergence

Another important consideration is Premenstrual Dysphoric Disorder (PMDD).

PMDD is more than typical premenstrual symptoms. It is a diagnosable condition characterized by severe mood, cognitive, behavioral, and physical symptoms that occur during the luteal phase of the menstrual cycle and typically improve shortly after menstruation begins. Symptoms may include marked irritability, emotional lability, depressed mood, anxiety, difficulty concentrating, fatigue, feeling overwhelmed, sleep changes, and significant impairment in daily functioning (American Psychiatric Association, 2022).

PMDD affects an estimated 3–8% of menstruating individuals in the general population, although prevalence estimates vary depending on diagnostic methods. Emerging evidence suggests PMDD may occur more frequently among individuals with ADHD, and a growing body of literature indicates autistic individuals may also experience elevated rates of significant premenstrual symptoms compared with the general population. However, additional high-quality research is still needed to better understand these relationships (Eng et al., 2024; Camara et al., 2022).

For neurodivergent individuals, PMDD may temporarily amplify executive functioning difficulties, sensory sensitivities, emotional regulation challenges, cognitive fatigue, and stress intolerance. During these periods, activities that are usually manageable may require substantially more effort.

Within the Bandwidth Model, PMDD can be conceptualized as another significant source of temporary physiological load that may reduce available bandwidth without changing an individual’s underlying neurodevelopmental architecture. As with the broader model, this represents a conceptual interpretation rather than an empirically validated mechanism.

It is also important to distinguish PMDD from Premenstrual Exacerbation (PME).

PMDD is a distinct psychiatric diagnosis characterized by cyclical symptoms that emerge during the luteal phase and resolve shortly after menstruation begins.

Premenstrual Exacerbation, in contrast, refers to the worsening of an existing condition—such as ADHD, autism-related challenges, depression, anxiety, PTSD, or another medical or psychiatric disorder—during the premenstrual phase.

This distinction matters because the underlying diagnosis, treatment recommendations, and prognosis may differ.

Because PMDD symptoms overlap with depression, anxiety disorders, trauma-related conditions, medication effects, thyroid disorders, and other medical conditions, careful assessment is essential. Current clinical guidelines recommend prospective daily symptom tracking across at least two menstrual cycles to improve diagnostic accuracy and distinguish PMDD from premenstrual exacerbation of another condition (American College of Obstetricians and Gynecologists, 2023).

Recognizing PMDD is important because effective treatments are available and may include lifestyle interventions, psychotherapy, selective serotonin reuptake inhibitors (SSRIs), hormonal treatments, or combinations of these approaches depending on the individual’s presentation, goals, and medical history.

Understanding the relationship between hormones and neurodivergence does not mean assuming every cyclical change represents PMDD. Instead, it highlights the importance of careful assessment, longitudinal symptom tracking, and individualized treatment planning so that biological influences are considered alongside psychological, environmental, and neurodevelopmental factors.

Although PMDD and PME can appear similar, they are not the same condition. PMDD is characterized by symptoms that emerge during the luteal phase and remit shortly after the onset of menstruation. In contrast, Premenstrual Exacerbation (PME) refers to the cyclical worsening of symptoms from an existing disorder—such as major depressive disorder, bipolar disorder, ADHD, anxiety disorders, PTSD, or other psychiatric conditions—while baseline symptoms remain present throughout the rest of the menstrual cycle. Distinguishing between PMDD and PME is important because diagnosis, treatment planning, and expected treatment response may differ. Prospective daily symptom ratings across at least two menstrual cycles remain the diagnostic standard for differentiating these conditions (American College of Obstetricians and Gynecologists, 2023; Eisenlohr-Moul et al., 2022; Reilly et al., 2024).

Why Some Adults Are Identified Later in Life

Many late-identified autistic adults describe reaching a point where strategies that had worked for decades suddenly stopped working.

For some individuals, that point appears to coincide with major hormonal transitions.

That does not mean hormones create autism or ADHD.

Rather, hormonal transitions may reduce the effectiveness of lifelong compensatory strategies, making previously masked or compensated neurodevelopmental differences more apparent (Bargiela et al., 2016; Moseley et al., 2020).

The characteristics were often present all along.

The person’s ability to compensate changed.

This distinction is important.

Late identification does not necessarily mean autism or ADHD suddenly appeared during adulthood. In many cases, individuals describe lifelong patterns that became more difficult to compensate for as biological demands, life responsibilities, cumulative stress, burnout, or hormonal transitions reduced their available cognitive resources.

For clinicians, this reinforces the importance of obtaining a thorough developmental history rather than assuming that the age of diagnosis reflects the age of onset.

A Bandwidth Model Perspective

Current evidence suggests hormonal transitions do not alter the underlying neurodevelopmental architecture of autism or ADHD.

Within the Bandwidth Model, hormonal transitions are conceptualized as one of many biological and environmental factors that may influence available bandwidth over time.

In this framework, available bandwidth represents the cognitive and regulatory resources a person has available at any given moment.

Hormonal transitions are one potential source of physiological load among many.

Other contributors may include:

• Sleep disruption

• Illness

• Chronic stress

• Trauma

• Sensory overload

• Pain

• Caregiving responsibilities

• Burnout

• Medication changes

• Nutritional status

• Environmental demands

When multiple sources of load accumulate simultaneously, the brain may have fewer resources available for executive functioning, emotional regulation, attention, working memory, cognitive flexibility, and sensory filtering.

From this perspective, hormones are not viewed as changing the underlying architecture of the brain.

Rather, they may temporarily influence how efficiently existing systems are functioning.

The underlying neurodevelopmental profile remains the same.

The amount of available capacity changes.

One of the strengths of this framework is that it encourages clinicians to consider the interaction between multiple factors rather than searching for a single cause of increased symptoms.

Sleep Often Becomes Part of the Story

Hormonal transitions frequently disrupt sleep quality and sleep continuity.

Sleep loss independently affects:

• Attention

• Working memory

• Executive functioning

• Emotional regulation

• Sensory processing

• Decision-making

• Cognitive flexibility

Consequently, reduced functioning during hormonal transitions may reflect both direct hormonal influences and the additional physiological load created by poor sleep (Zhu et al., 2022).

Sleep disruption itself can substantially impair executive functioning, making it difficult to distinguish direct hormonal effects from the downstream effects of inadequate sleep.

In clinical practice, this distinction matters because improving sleep quality may reduce cognitive difficulties even when hormonal transitions continue.

The Nervous System Matters Too

Hormones also influence autonomic nervous system activity and physiological stress responsiveness (Shansky & Woolley, 2016).

Changes in autonomic regulation may contribute to differences in:

• Arousal

• Emotional regulation

• Stress tolerance

• Cognitive performance

• Fatigue

• Recovery following stress

Although these interactions are complex and vary considerably between individuals, they illustrate that cognitive functioning cannot always be understood by examining the brain in isolation.

The brain, body, endocrine system, immune system, and autonomic nervous system continuously influence one another.

Heat Can Become Another Source of Load

Some autistic and ADHD individuals report greater cognitive fatigue during hot weather or during vasomotor symptoms such as hot flashes.

Although research specifically examining heat intolerance in neurodivergent adults remains limited, heat increases physiological demands on the body and may indirectly affect cognition through dehydration, fatigue, sleep disruption, and increased physiological load (Zhu et al., 2022).

Heat is unlikely to explain everything.

But for some people, it may represent another demand competing for already limited cognitive resources.

This illustrates an important principle:

Sometimes several relatively small physiological demands combine to produce a much larger effect on day-to-day functioning.

A Clinical Perspective

One of the questions I increasingly find helpful is not simply:

“What symptoms are present?”

but also:

“Where is this person in their hormonal life stage?”

That question does not replace careful assessment.

It adds important clinical context.

Clinicians should also consider alternative or co-occurring explanations for cognitive or emotional changes, including:

• Thyroid disorders

• Anemia

• Medication effects

• Sleep disorders

• Nutritional deficiencies

• Depression

• Anxiety disorders

• Trauma-related disorders

• Chronic medical conditions

• Substance use

• Other neurological or medical conditions

Hormones are one possible contributor—not the only one.

Current evidence in this area is still evolving, particularly regarding autism and menopause. Much of the literature consists of qualitative studies, observational research, systematic reviews, and clinical reviews rather than large prospective trials. As additional research emerges, our understanding of these relationships will continue to improve.

The Bottom Line

Not every increase in symptoms represents a worsening disorder.

Sometimes it reflects a nervous system working with fewer available resources because of temporary biological changes.

Sometimes it reflects the interaction of hormones with sleep disruption, chronic stress, illness, sensory load, burnout, caregiving demands, or other sources of physiological burden.

Understanding these interactions can reduce unnecessary self-blame while improving assessment and treatment planning.

Rather than asking,

“Why am I suddenly falling apart?”

it may sometimes be more accurate to ask,

“What additional load is my nervous system carrying right now?”

That question doesn’t answer everything.

But it often opens the door to a more compassionate—and, perhaps more importantly, a more accurate—understanding of human functioning.

As research on neurodivergence and hormonal transitions continues to evolve, understanding these biological influences may help clinicians and individuals make more individualized, evidence-informed decisions about assessment, support, treatment, and self-care.

Ultimately, recognizing the role of hormones is not about reducing people to biology.

It is about appreciating the complex interaction between neurodevelopment, physiology, environment, and lived experience—and using that understanding to support more personalized, compassionate, and effective care.

Bandwidth Model™ Disclaimer

The Bandwidth Model™ is an original conceptual framework developed by Darcy Stephens, LPCC, to help organize and communicate current scientific knowledge related to neurodevelopment, cognitive capacity, nervous system regulation, physiological state, environmental demands, and functional load.

The model integrates findings from multiple areas of research—including neuroscience, psychology, psychiatry, endocrinology, stress physiology, and cognitive science—but has not yet been empirically validated as an independent scientific model.

The references included in this article support the individual scientific concepts discussed and should not be interpreted as direct validation of the Bandwidth Model™ itself.

The model is intended to promote clinical reasoning, individualized assessment, psychoeducation, and hypothesis generation. It is not intended to replace evidence-based assessment, diagnosis, or treatment.

Educational Disclaimer

This article is intended for educational and informational purposes only.

It is not intended to provide medical advice or to replace individualized medical, psychological, or mental health assessment, diagnosis, or treatment.

If you are experiencing significant changes in cognition, mood, executive functioning, menstrual symptoms, or overall functioning, consult a qualified healthcare professional for individualized evaluation and recommendations.

References

American College of Obstetricians and Gynecologists. (2023). Clinical Practice Guideline No. 2: Management of Premenstrual Disorders.Obstetrics & Gynecology, 142(3), e1–e53. https://doi.org/10.1097/AOG.0000000000005334

American Psychiatric Association. (2022). Diagnostic and Statistical Manual of Mental Disorders (5th ed., text rev.; DSM-5-TR). American Psychiatric Association.

Bargiela, S., Steward, R., & Mandy, W. (2016). The experiences of late-diagnosed women with autism spectrum conditions.Journal of Autism and Developmental Disorders, 46(10), 3281–3294. https://doi.org/10.1007/s10803-016-2872-8

Camara, B., Padoin, C., & Bolea, B. (2022). Relationship between sex hormones, reproductive stages and ADHD: A systematic review.Archives of Women’s Mental Health, 25(1), 1–8. https://doi.org/10.1007/s00737-021-01181-w

Eisenlohr-Moul, T. A., et al. (2022). Toward the reliable diagnosis of DSM-5 Premenstrual Dysphoric Disorder and Premenstrual Exacerbation: The Carolina Premenstrual Assessment Scoring System (C-PASS). American Journal of Psychiatry Open. https://doi.org/10.1176/appi.ajp.2016.15121510

Eng, A. G., Nirjar, U., Elkins, A. R., Sizemore, Y. J., Monticello, K. N., Petersen, M. K., Miller, S. A., Barone, J., Eisenlohr-Moul, T. A., & Martel, M. M. (2024). Attention-deficit/hyperactivity disorder and the menstrual cycle: Theory and evidence.Hormones and Behavior, 158, 105466. https://doi.org/10.1016/j.yhbeh.2023.105466

Moseley, R. L., Druce, T., & Turner-Cobb, J. M. (2020). “When my autism broke”: A qualitative study spotlighting autistic voices on menopause.Autism, 24(6), 1423–1437. https://doi.org/10.1177/1362361319901184

Reilly, T. J., Patel, S., Unachukwu, I. C., Knox, C. L., Wilson, C. A., Craig, M. C., Schmalenberger, K. M., Eisenlohr-Moul, T. A., & Cullen, A. E. (2024). The prevalence of premenstrual dysphoric disorder: Systematic review and meta-analysis. Journal of Affective Disorders, 349, 534–540. https://doi.org/10.1016/j.jad.2024.01.066

Shansky, R. M., & Woolley, C. S. (2016). Considering sex as a biological variable will improve neuroscience research.Journal of Neuroscience, 36(47), 11817–11822. https://doi.org/10.1523/JNEUROSCI.1390-16.2016

Zhu, C., Thomas, N., Arunogiri, S., & Gurvich, C. (2022). Systematic review and narrative synthesis of cognition in perimenopause: The role of risk factors and menopausal symptoms.Maturitas, 164, 76–86. https://doi.org/10.1016/j.maturitas.2022.06.010